カテゴリ： MarketLine, イギリス, 企業調査

GlaxoSmithKline Plc：企業の戦略・SWOT・財務情報

◆英語タイトル：GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4427
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：73
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

GlaxoSmithKline Plc – Strategy, SWOT and Corporate Finance Report
Summary

GlaxoSmithKline Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or ‘the company’) is a leading global provider of pharmaceuticals, vaccines and consumer healthcare products. It is primarily involved in developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. These cater to the needs of HIV, respiratory, cancer, anti-virals, metabolic, cardiovascular and urogenital, dermatology, anti-bacterials and several other rare diseases. It merchandise and sell these products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in England, the UK.

Scope

- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
GlaxoSmithKline Plc: Company Overview 9
GlaxoSmithKline Plc: Overview and Key Facts 9
GlaxoSmithKline Plc: Overview 9
GlaxoSmithKline Plc: Key Facts 9
GlaxoSmithKline Plc: Key Employees 11
GlaxoSmithKline Plc: Key Employee Biographies 13
GlaxoSmithKline Plc: Major Products and Services 20
GlaxoSmithKline Plc: Company History 22
GlaxoSmithKline Plc: Management Statement 37
GlaxoSmithKline Plc: Locations and Subsidiaries 39
GlaxoSmithKline Plc: Key Competitors 41
GlaxoSmithKline Plc: Company Analysis 42
GlaxoSmithKline Plc: Business Description 42
GlaxoSmithKline Plc: SWOT Analysis 44
GlaxoSmithKline Plc: SWOT Overview 44
GlaxoSmithKline Plc: Strengths 44
GlaxoSmithKline Plc: Weaknesses 45
GlaxoSmithKline Plc: Opportunities 46
GlaxoSmithKline Plc: Threats 47
GlaxoSmithKline Plc: Corporate Financial Deals Activity 49
GlaxoSmithKline Plc: Financial Deals Overview 49
GlaxoSmithKline Plc: Targets and Partners 51
GlaxoSmithKline Plc: Top Deals 2014 – 2018YTD* 54
GlaxoSmithKline Plc: Advisors 55
GlaxoSmithKline Plc: Top Legal Advisors 55
GlaxoSmithKline Plc: Top Financial Advisors 55
GlaxoSmithKline Plc: Mergers and Acquisitions 57
GlaxoSmithKline Plc: Corporate Venturing 58
GlaxoSmithKline Plc: Capital Raising 59
GlaxoSmithKline Plc: Partnership 60
GlaxoSmithKline Plc: Divestments 61
GlaxoSmithKline Plc: Recent Developments 62
GlaxoSmithKline Plc: News and Events Summary 62
GlaxoSmithKline Plc: Business Expansion 66
GlaxoSmithKline Plc: Business Reorganization 66
GlaxoSmithKline Plc: Contracts 67
GlaxoSmithKline Plc: Financial Deals 67
GlaxoSmithKline Plc: Financial Performance 68
GlaxoSmithKline Plc: Market Developments 68
GlaxoSmithKline Plc: Red Flags/DistressSignals 69
GlaxoSmithKline Plc: Regulatory and Legal Events 69
GlaxoSmithKline Plc: Strategy and Operations 70
Appendix 71
Contact Us 71
Methodology 71
About MarketLine 72

List of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 3: GlaxoSmithKline Plc: Locations and Subsidiaries
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 9: GlaxoSmithKline Plc: Targets and Partners
Table 10: GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*
Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)
Table 23: GlaxoSmithKline Plc: News and Events Summary
Table 24: GlaxoSmithKline Plc: Business Expansion
Table 25: GlaxoSmithKline Plc: Business Reorganization
Table 26: GlaxoSmithKline Plc: Contracts
Table 27: GlaxoSmithKline Plc: Financial Deals
Table 28: GlaxoSmithKline Plc: Financial Performance
Table 29: GlaxoSmithKline Plc: Market Developments
Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 32: GlaxoSmithKline Plc: Strategy and Operations

List of Figures
Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[GlaxoSmithKline Plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Printpack Inc：企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Purdue Pharma Canada-製薬・医療分野：企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • Yangarra Resources Ltd (YGR)：企業の財務・戦略的SWOT分析
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • RadiSys Corp (RSYS)：企業の財務・戦略的SWOT分析
    Summary RadiSys Corp (RadiSys) is a provider of communication services. The company offers products include mobility engine, mediaengine, dcengine and embedded Products. It offers contact support, serviceengine, conceptualization, software customization, network design and integration; testing and a …
  • Clinical Laserthermia Systems AB (CLS B)：企業の製品パイプライン分析2018
    Summary Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a preci …
  • Thales USA, Inc.：戦略・SWOT・企業財務分析
    Thales USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thales USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Velatia SL：企業の戦略的SWOT分析
    Velatia SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Kier Group Plc (KIE)：企業の財務・戦略的SWOT分析
    Kier Group Plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ansvar Insurance Limited
    Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • 3i Group Plc：企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • AFC Energy plc (AFC)：企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. Its power generation technology is used in the industrial markets and produces heat, water, and electricity. AFC Energy provides its electricity for industrial applicati …
  • University of Wisconsin Madison：製薬・医療：M&Aディール及び事業提携情報
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …
  • REVA Medical Inc (RVA)：医療機器：M&Aディール及び事業提携情報
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • Starbreeze AB (STAR B)：企業の財務・戦略的SWOT分析
    Summary Starbreeze AB (Starbreeze) is a game development company that creates, publishes and distributes entertainment products and games. The company’s published games include the outforce, enclave, knights of the temple, syndicate, the chronicles of riddick, knights of the temple, enclave, escapes …
  • Mosenergo (MSNG)：電力：M&Aディール及び事業提携情報
    Summary Mosenergo, a subsidiary of Gazprom Energoholding LLC, is a power utility. It generates electricity and thermal energy using natural gas, coal, fuel oil, and diesel sources. The company owns and operates power plants: TPP-20, SDPP-3, TPP-9, SPP-1, TPP-21, TPP-8, TPP-11, TPP-16, TPP-12, TPP-17 …
  • Entegris Inc (ENTG)：企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Sinopec Shanghai Petrochemical Company Limited：戦略・SWOT・企業財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Bonavista Energy Corp (BNP)：企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Genenta Science srl：製薬・医療：M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • Pacific World Corporation：企業の戦略・SWOT・財務情報
    Pacific World Corporation - Strategy, SWOT and Corporate Finance Report Summary Pacific World Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆